Seer (SEER) Set to Release Quarterly Earnings on Tuesday

Key Points

• Seer is expected to report Q3 2026 results after Tuesday’s market close, with analysts projecting a loss of $0.26 per share and revenue of $4.15 million.
• The company missed expectations in the prior quarter, reporting a $0.31-per-share loss and $3.10 million in revenue versus estimates of a $0.27 loss and $3.55 million in revenue.
• Seer shares opened at $1.73, near their one-year low, while analyst sentiment remains mixed: two analysts rate the stock a Strong Buy and one rates it Sell; the consensus rating is Buy with a $4.00 price target.

Seer (NASDAQ:SEER - Get Free Report) is projected to announce its Q3 2026 results after the market closes on Tuesday, November 10th. Analysts expect the company to announce earnings of ($0.26) per share and revenue of $4.15 million for the quarter. Individuals can check the company's upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Tuesday, November 10, 2026 at 4:30 PM ET.

Seer (NASDAQ:SEER - Get Free Report) last issued its quarterly earnings data on Tuesday, August 11th. The company reported ($0.31) EPS for the quarter, missing the consensus estimate of ($0.27) by ($0.04). The firm had revenue of $3.10 million for the quarter, compared to analysts' expectations of $3.55 million. Seer had a negative net margin of 478.05% and a negative return on equity of 27.23%.

Seer Price Performance

SEER opened at $1.73 on Tuesday. Seer has a one year low of $1.55 and a one year high of $2.38. The company has a fifty day moving average price of $2.00 and a 200-day moving average price of $1.92. The firm has a market capitalization of $95.79 million, a P/E ratio of -1.42 and a beta of 1.47.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a "sell (d-)" rating on shares of Seer in a report on Thursday, October 15th. Two equities research analysts have rated the stock with a Strong Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Buy" and a consensus price target of $4.00.

Seer Company Profile

Seer, Inc is a life sciences company that develops technologies for large-scale protein analysis, known as proteomics. The company's platform is designed to help researchers study a broad range of proteins in biological samples and generate detailed information that may support drug discovery, disease research and biomarker development.

Seer's primary offering is the Proteograph Product Suite, which combines engineered nanoparticle technology, laboratory consumables, automation and software.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.